Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
NRG Oncology
NRG Oncology
UNC Lineberger Comprehensive Cancer Center
Genmab
Fulgent Pharma LLC.
Hoffmann-La Roche
Eastern Cooperative Oncology Group
University of Chicago
University of Chicago
Neonc Technologies, Inc.
Gilead Sciences
NRG Oncology
University of Pittsburgh